Siemens launches new Biograph Horizon PET/CT system

16 December 2015 (Last Updated December 16th, 2015 18:30)

Siemens Healthcare has introduced the new Biograph Horizon PET/CT system to address a range of clinical indications in the fields of oncology, neurology and cardiology.

Siemens

Siemens Healthcare has introduced the new Biograph Horizon PET/CT system to address a range of clinical indications in the fields of oncology, neurology and cardiology.

With the system, clinicians will have the capability to serve a broad range of patients and expand into new service areas. It allows the use of all commercially available PET tracers, giving users the ability to address more indications in these fields.

The system uses 4mm LSO crystals to offer rapid scintillation with improved output, providing better image quality using the lowest achievable dose to help clinicians with visualising small lesions.

It also includes built-in capabilities, which automates routine tasks to increase productivity and streamline workflows.

The Quanti-QC system is said to run quality control procedures overnight to save clinics time. Scans can be carried out in five minutes, and reconstruction runs besides acquisition for image delivery 30 seconds after the scan.

"The Biograph Horizon provides a cost-effective PET/CT imaging solution that does not compromise on quality."

Siemens Healthcare sales director Steve Holmes said: "At a time when there is a demand to drive down cost while enhancing productivity, Siemens is well placed to support with technology capable of improving care pathways and maximising investments.

"The Biograph Horizon provides a cost-effective PET/CT imaging solution that does not compromise on quality.

"As our smallest PET/CT system, it offers low power requirements and a small footprint to ensure reduced operating and maintenance costs, with the flexibility to meet expanding clinical needs."

In addition, the system uses the syngo.via molecular imaging workplace image processing solution to expand clinical possibilities.

The solution provides automated tools to instantly visualise diagnostic information, automate pre-fetching, pre-processing, and display and comparison of previous findings.

The company noted that ALPHA technology provides automatic registration with organ-based recognition capabilities and EQ/PET feature provides precise calculation of changes in tumour uptake.


Image: Siemens Healthcare's new Biograph Horizon PET/CT system. Photo: courtesy of Siemens AG.